Company
Every investor coverage indicates participated in a round INSEAD raised.
Companies INSEAD acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming INSEAD. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Neurizon Therapeutics, a Melbourne biotech developing an ALS treatment, has appointed industry veteran Dr Chris Bremer as CEO as its lead drug NUZ-001 heads toward Phase 2/3 trial results in 2027.
Forbes Australia interviews Amal Clooney at the Cartier Women's Initiative 2026 celebration in Bangkok, where she mentored female founder fellows, including three Australian award winners, and discussed her justice foundation's legal-aid work.
Cartier’s 2024 Women’s Initiative honoured 33 women entrepreneurs with tiered grant prizes, including Australians Alison Harrington of Resparke and Frances Bilbao of Mums Matter Psychology and New Zealand’s Simran Kaur of Girls That Invest.
A Q&A with the Plexus chief executive covering the company's 2011 founding, its Legal Gateway platform, client pricing reform, emerging legal roles, and his outlook for the profession.